Cryo-Cell International, Inc. (CCEL) Earnings History
Net Loss30 years of earnings data (1996–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Cryo-Cell International, Inc. (CCEL) Earnings Overview
As of June 28, 2026, Cryo-Cell International, Inc. (CCEL) reported trailing twelve-month net income of -$3M, reflecting -700.0% year-over-year growth. The company earned $-0.33 per diluted share over the past four quarters, with a net profit margin of -7.7%.
Looking at the long-term picture, CCEL's historical earnings data spans multiple years. The company achieved its highest annual net income of $8M in fiscal 2015.
Cryo-Cell International, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including VCEL ($21M net income, 6.0% margin), BLFS (-$10M net income, -12.6% margin), IART (-$496M net income, -31.6% margin), CCEL has room to improve margins relative to the peer group. Compare CCEL vs VCEL →
CCEL Earnings vs Peers
Earnings metrics vs comparable public companies
CCEL Historical Earnings Data (1996–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$2M | -704.2% | $5M | $-0.30 | -7.7% | 15.3% |
| 2024 | $402,095 | +104.2% | $3M | $0.05 | 1.3% | 10.9% |
| 2023 | -$10M | -443.6% | -$12M | $-1.14 | -30.4% | -39.3% |
| 2022 | $3M | +33.0% | $4M | $0.33 | 9.1% | 13.3% |
| 2021 | $2M | -42.5% | $4M | $0.25 | 7.2% | 13.9% |
| 2020 | $4M | +58.2% | $8M | $0.45 | 11.6% | 24.6% |
| 2019 | $2M | +368.0% | $5M | $0.27 | 7.2% | 15.9% |
| 2018 | $-854,824 | -136.9% | $5M | $-0.11 | -2.9% | 17.8% |
| 2017 | $2M | +275.3% | $5M | $0.30 | 9.1% | 19.7% |
| 2016 | -$1M | -116.3% | $433,594 | $-0.16 | -5.7% | 1.9% |
| 2015 | $8M | +1364.2% | $3M | $0.83 | 38.4% | 13.9% |
| 2014 | $553,623 | +1917.9% | $2M | $0.05 | 2.8% | 9.8% |
| 2013 | $27,436 | +100.4% | $2M | $0.00 | 0.1% | 9.0% |
| 2012 | -$6M | -201.0% | -$2M | $-0.56 | -35.1% | -9.5% |
| 2011 | -$2M | -161.4% | $-276,742 | $-0.18 | -11.7% | -1.5% |
| 2010 | $3M | +139.4% | $3M | $0.29 | 19.3% | 18.3% |
| 2009 | $1M | +287.4% | $2M | $0.12 | 8.7% | 10.2% |
| 2008 | $-760,419 | +84.8% | $-326,746 | $-0.06 | -4.4% | -1.9% |
| 2007 | -$5M | -78.0% | -$5M | $-0.43 | -28.7% | -26.8% |
| 2006 | -$3M | -372.0% | -$3M | $-0.24 | -16.4% | -17.2% |
| 2005 | $1M | -63.6% | $1M | $0.08 | 7.2% | 8.5% |
| 2004 | $3M | +137.8% | $3M | $0.24 | 23.3% | 26.0% |
| 2003 | -$8M | -41.2% | -$8M | $-0.66 | -99.6% | -99.6% |
| 2002 | -$5M | -692.2% | -$6M | $-0.47 | -75.3% | -78.3% |
| 2001 | $899,634 | +160.4% | $-485,889 | $0.09 | 15.9% | -8.6% |
| 2000 | -$1M | -148.4% | -$2M | $-0.15 | -70.7% | -102.5% |
| 1999 | $-600,000 | +73.9% | -$1M | $-0.07 | -35.3% | -58.8% |
| 1998 | -$2M | -43.8% | -$2M | $-0.32 | -766.7% | -800.0% |
| 1997 | -$2M | -366.7% | -$2M | $-0.23 | -400.0% | -425.0% |
| 1996 | $600,000 | - | $800,000 | $0.09 | 22.2% | 29.6% |
Download Data
Export CCEL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CCEL — Frequently Asked Questions
Quick answers to the most common questions about buying CCEL stock.
What is CCEL earnings per share (EPS)?
CCEL trailing twelve-month (TTM) diluted EPS is $-0.33, reflecting -700.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1996 to 2025 is available in the table on this page.
What is Cryo-Cell International, Inc.'s net income?
Cryo-Cell International, Inc. (CCEL) trailing twelve-month net income is $-3M as of 2025. Earnings declined -700.0% year-over-year.
Is CCEL profitable?
CCEL is not currently profitable on a TTM basis, reporting a net loss of $-3M. Net margin is -7.7%. Investors should monitor for a return to profitability.
What is CCEL's earnings growth rate?
CCEL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1996 to 2025.
What are CCEL's profit margins?
Cryo-Cell International, Inc. net profit margin is -7.7%, operating margin is +15.3%, and gross margin is +76.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is CCEL growing earnings?
CCEL earnings are declining — EPS fell -700.0% year-over-year. TTM net income dropped to $-3M. This contrasts with the 5-year CAGR of N/A.
What was CCEL's best earnings year?
Cryo-Cell International, Inc.'s highest annual net income on record is $8M, achieved in fiscal year 2015. Earnings history on this page spans 1996 to 2025 and includes all annual and quarterly figures.
What were CCEL's earnings last quarter?
CCEL's most recent reported quarter was Q1 2026. Net income was $47108.00 with diluted EPS of $0.01. For a full breakdown of all quarters, see the quarterly earnings table on this page.